Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9166 USD | +0.94% |
|
-8.34% | -84.33% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 117 | 58.39 | 284 | 44.88 | - | - |
Enterprise Value (EV) 1 | 90.3 | 58.39 | 284 | 39.92 | 44.88 | 44.88 |
P/E ratio | -5.08 x | -2.39 x | -13.3 x | -1.67 x | -1.92 x | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 5.28 x | 1.89 x | 6.33 x | 0.84 x | 0.67 x | 0.72 x |
EV / Revenue | 4.07 x | 1.89 x | 6.33 x | 0.75 x | 0.67 x | 0.72 x |
EV / EBITDA | -5.88 x | -3.14 x | -18.7 x | -1.76 x | -2.53 x | -3.56 x |
EV / FCF | -4.7 x | -3.21 x | -15.3 x | -1.73 x | -2.86 x | -4.4 x |
FCF Yield | -21.3% | -31.1% | -6.53% | -57.9% | -35% | -22.7% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 37,158 | 37,432 | 48,555 | 48,968 | - | - |
Reference price 2 | 3.150 | 1.560 | 5.850 | 0.9166 | 0.9166 | 0.9166 |
Announcement Date | 3/21/22 | 3/27/23 | 3/18/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | 22.16 | 30.93 | 44.86 | 53.2 | 66.58 | 62 |
EBITDA 1 | - | - | -15.35 | -18.59 | -15.21 | -22.67 | -17.77 | -12.6 |
EBIT 1 | - | - | -17.94 | -22.37 | -18.78 | -26.41 | -21.79 | -14.6 |
Operating Margin | - | - | -80.93% | -72.32% | -41.87% | -49.64% | -32.74% | -23.55% |
Earnings before Tax (EBT) 1 | - | - | -17.85 | -24.45 | -19.03 | -29.1 | -25.66 | - |
Net income 1 | -18.5 | -15.6 | -17.85 | -24.45 | -19.17 | -29.08 | -25.72 | - |
Net margin | - | - | -80.54% | -79.04% | -42.74% | -54.66% | -38.63% | - |
EPS 2 | -9.360 | -2.220 | -0.6200 | -0.6534 | -0.4400 | -0.5475 | -0.4767 | - |
Free Cash Flow 1 | - | - | -19.2 | -18.18 | -18.55 | -23.1 | -15.7 | -10.2 |
FCF margin | - | - | -86.64% | -58.78% | -41.35% | -43.42% | -23.58% | -16.45% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 2/8/21 | 3/31/21 | 3/21/22 | 3/27/23 | 3/18/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 6.577 | 6.985 | 7.333 | 7.864 | 8.751 | 9.628 | 10.78 | 11.77 | 12.68 | 13.47 | 13.64 | 12.92 | 13.18 | 15.07 | 16.28 |
EBITDA 1 | -3.838 | -4.688 | -5.257 | -4.52 | -4.178 | -4.148 | -3.597 | -3.079 | -3.306 | -5.078 | -5.589 | -6.107 | -5.918 | -5.206 | -4.618 |
EBIT 1 | -4.827 | -5.445 | -6.051 | -5.458 | -5.44 | -5.094 | -4.934 | -4.403 | -4.347 | -6.402 | -6.495 | -6.978 | -6.833 | -6.777 | -6.045 |
Operating Margin | -73.39% | -77.95% | -82.52% | -69.4% | -62.16% | -52.91% | -45.77% | -37.42% | -34.28% | -47.52% | -47.62% | -54.03% | -51.85% | -44.95% | -37.13% |
Earnings before Tax (EBT) 1 | -5.451 | -5.936 | -7.447 | -5.49 | -5.599 | -5.239 | -5.033 | -4.407 | -4.515 | -6.579 | -7.151 | -7.746 | -7.62 | -7.209 | -6.502 |
Net income 1 | -5.451 | -5.936 | -7.447 | -5.49 | -5.599 | -5.239 | -5.033 | -4.407 | -4.491 | -6.499 | -7.161 | -7.757 | -7.632 | -7.226 | -6.522 |
Net margin | -82.88% | -84.98% | -101.55% | -69.81% | -63.98% | -54.41% | -46.69% | -37.45% | -35.42% | -48.24% | -52.5% | -60.06% | -57.92% | -47.94% | -40.06% |
EPS 2 | -0.1600 | -0.1600 | -0.2000 | -0.1500 | -0.1453 | -0.1397 | -0.1200 | -0.1000 | -0.0900 | -0.1200 | -0.1350 | -0.1450 | -0.1450 | -0.1350 | -0.1200 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/21/22 | 5/9/22 | 8/8/22 | 11/14/22 | 3/27/23 | 5/15/23 | 8/7/23 | 11/6/23 | 3/18/24 | 5/13/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - | - |
Net Cash position 1 | - | - | 26.8 | - | - | 4.96 | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | -19.2 | -18.2 | -18.5 | -23.1 | -15.7 | -10.2 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | 0.61 | 1.41 | - | - | - | - |
Capex / Sales | - | - | 2.76% | 4.55% | - | - | - | - |
Announcement Date | 2/8/21 | 3/31/21 | 3/21/22 | 3/27/23 | 3/18/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.33% | 44.88M | |
+19.76% | 73.23B | |
+10.89% | 18.02B | |
+18.76% | 14.53B | |
+16.05% | 13.13B | |
+14.46% | 10.18B | |
-15.15% | 7.28B | |
-6.51% | 5.84B | |
+7.29% | 5.38B | |
+4.60% | 5.33B |
- Stock Market
- Equities
- AUGX Stock
- Financials Augmedix, Inc.